Giessen, Germany; Division Bioresources, Fraunhofer Institute for Molecular Biology and
Applied Ecology (IME), Giessen, Germany
TALES FERNANDO DA SILVA • Laboratory of Cellular and Molecular Genetics (LGCM),
Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal
University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil
AKSHAY DATEY • Centre for Biosystems Science and Engineering, Indian Institute of Science,
Bengaluru, India
XAVIER DAURA • Institute of Biotechnology and Biomedicine, Universitat Auto `noma de
Barcelona, Cerdanyola del Valle `s, Spain; Catalan Institution for Research and Advanced
Studies (ICREA), Barcelona, Spain
LUIS CLA ´ UDIO LIMA DE JESUS • Laboratory of Cellular and Molecular Genetics (LGCM),
Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal
University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil
GREGOR DEKEVIC • Institute of Bioprocess Engineering and Pharmaceutical Technology
(IBPT), Technische Hochschule Mittelhessen (THM) - University of Applied Sciences,
Giessen, Germany
ROBERTA DI BENEDETTO • GSK Vaccines Institute for Global Health, Siena, Italy
DIANA DIAZ-ARE ´ VALO • Grupo Funcional de Inmunologı ´a, Fundaci on Instituto de
Inmunologı ´a de Colombia-FIDIC, School of Medicine and Health Sciences, Universidad
del Rosario, Bogota ´ , D.C., Colombia
NICOLE DINARDO • Thermo Fisher Scientific Inc., Grand Island, NY, USA
MIHAELA-OLIVIA DOBRICA • Institute of Biochemistry of the Romanian Academy, Bucharest,
Romania
MARIANA MARTINS DRUMOND • Laboratory of Cellular and Molecular Genetics (LGCM),
Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal
University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil; Department of
Biological Sciences, Federal Center for Technological Education of Minas Gerais (CEFET/
MG), Belo Horizonte, Minas Gerais, Brazil
KASHYAP KUMAR DUBEY • Department of Biotechnology, Central University of Haryana,
Mahendergarh, Haryana, India
RENU DUDANI • Human Health Therapeutics, National Research Council Canada,
Ottawa, ON, Canada
FRIEDERIKE EILTS • Institute of Bioprocess Engineering and Pharmaceutical Technology
(IBPT), Technische Hochschule Mittelhessen (THM) - University of Applied Sciences,
Giessen, Germany
JOHN T. ELLIS • School of Life Sciences, University of Technology Sydney (UTS), Ultimo, NSW,
Australia
TIMM FIEBIG • Institute of Clinical Biochemistry, Hannover Medical School, Hannover,
Germany
YASMINE GABAL • School of Chemical Engineering, Oklahoma State University, Stillwater,
OK, USA
CARLO GIANNELLI • GSK Vaccines Institute for Global Health, Siena, Italy
CAMILLA A. GLADSTONE • Section of Paediatric Infectious Disease, Department of Infectious
Disease, Imperial College London, London, UK
STEPHEN J. GOODSWEN • School of Life Sciences, University of Technology Sydney (UTS),
Ultimo, NSW, Australia
xii
Contributors
Applied Ecology (IME), Giessen, Germany
TALES FERNANDO DA SILVA • Laboratory of Cellular and Molecular Genetics (LGCM),
Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal
University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil
AKSHAY DATEY • Centre for Biosystems Science and Engineering, Indian Institute of Science,
Bengaluru, India
XAVIER DAURA • Institute of Biotechnology and Biomedicine, Universitat Auto `noma de
Barcelona, Cerdanyola del Valle `s, Spain; Catalan Institution for Research and Advanced
Studies (ICREA), Barcelona, Spain
LUIS CLA ´ UDIO LIMA DE JESUS • Laboratory of Cellular and Molecular Genetics (LGCM),
Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal
University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil
GREGOR DEKEVIC • Institute of Bioprocess Engineering and Pharmaceutical Technology
(IBPT), Technische Hochschule Mittelhessen (THM) - University of Applied Sciences,
Giessen, Germany
ROBERTA DI BENEDETTO • GSK Vaccines Institute for Global Health, Siena, Italy
DIANA DIAZ-ARE ´ VALO • Grupo Funcional de Inmunologı ´a, Fundaci on Instituto de
Inmunologı ´a de Colombia-FIDIC, School of Medicine and Health Sciences, Universidad
del Rosario, Bogota ´ , D.C., Colombia
NICOLE DINARDO • Thermo Fisher Scientific Inc., Grand Island, NY, USA
MIHAELA-OLIVIA DOBRICA • Institute of Biochemistry of the Romanian Academy, Bucharest,
Romania
MARIANA MARTINS DRUMOND • Laboratory of Cellular and Molecular Genetics (LGCM),
Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal
University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil; Department of
Biological Sciences, Federal Center for Technological Education of Minas Gerais (CEFET/
MG), Belo Horizonte, Minas Gerais, Brazil
KASHYAP KUMAR DUBEY • Department of Biotechnology, Central University of Haryana,
Mahendergarh, Haryana, India
RENU DUDANI • Human Health Therapeutics, National Research Council Canada,
Ottawa, ON, Canada
FRIEDERIKE EILTS • Institute of Bioprocess Engineering and Pharmaceutical Technology
(IBPT), Technische Hochschule Mittelhessen (THM) - University of Applied Sciences,
Giessen, Germany
JOHN T. ELLIS • School of Life Sciences, University of Technology Sydney (UTS), Ultimo, NSW,
Australia
TIMM FIEBIG • Institute of Clinical Biochemistry, Hannover Medical School, Hannover,
Germany
YASMINE GABAL • School of Chemical Engineering, Oklahoma State University, Stillwater,
OK, USA
CARLO GIANNELLI • GSK Vaccines Institute for Global Health, Siena, Italy
CAMILLA A. GLADSTONE • Section of Paediatric Infectious Disease, Department of Infectious
Disease, Imperial College London, London, UK
STEPHEN J. GOODSWEN • School of Life Sciences, University of Technology Sydney (UTS),
Ultimo, NSW, Australia
xii
Contributors